AU535944B2
(en)
*
|
1979-06-15 |
1984-04-12 |
Merck & Co., Inc. |
Hypocholestermic fermentation products from aspergillus
|
US4710513A
(en)
*
|
1979-08-17 |
1987-12-01 |
Merck & Co., Inc. |
Substituted pyranone inhibitors of cholesterol synthesis
|
US4567289A
(en)
*
|
1979-08-17 |
1986-01-28 |
Merck & Co., Inc. |
Substituted pyranone inhibitors of cholesterol synthesis
|
US4459422A
(en)
*
|
1979-08-17 |
1984-07-10 |
Merck & Co., Inc. |
Substituted pyranone inhibitors of cholesterol synthesis
|
IL60751A
(en)
*
|
1979-08-17 |
1985-04-30 |
Merck & Co Inc |
6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
|
US4293496A
(en)
*
|
1980-02-04 |
1981-10-06 |
Merck & Co., Inc. |
6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
|
US4440927A
(en)
*
|
1981-06-19 |
1984-04-03 |
Merck & Co., Inc. |
Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
|
EP0068038B1
(fr)
*
|
1981-06-29 |
1985-09-25 |
Merck & Co. Inc. |
(+)-(4R.6S)-(E)-6-(2-(4'-fluoro-3,3',5-triméthyl-(1,1'-biphényl)-2-yle)éthenyl)-3,4,5,6-tétrahydro-4-hydroxy-2H-pyran-2-one, un procédé pour sa fabrication et une composition pharmaceutique la contenant
|
US4739073A
(en)
*
|
1983-11-04 |
1988-04-19 |
Sandoz Pharmaceuticals Corp. |
Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
|
US5354772A
(en)
*
|
1982-11-22 |
1994-10-11 |
Sandoz Pharm. Corp. |
Indole analogs of mevalonolactone and derivatives thereof
|
CA1282425C
(fr)
*
|
1984-06-04 |
1991-04-02 |
Meyer Sletzinger |
Procede de preparation d'inhibiteurs de la hmg-coa reductase avec une sous-unite de 3,5-dihihydroxypentanoate
|
US4645854A
(en)
*
|
1985-04-25 |
1987-02-24 |
Merck & Co., Inc. |
Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit
|
US4588715A
(en)
*
|
1984-06-04 |
1986-05-13 |
Sandoz, Inc. |
Heptenoic acid derivatives
|
US4613610A
(en)
*
|
1984-06-22 |
1986-09-23 |
Sandoz Pharmaceuticals Corp. |
Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
|
US4686237A
(en)
*
|
1984-07-24 |
1987-08-11 |
Sandoz Pharmaceuticals Corp. |
Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
|
US4804679A
(en)
*
|
1984-07-24 |
1989-02-14 |
Sandoz Pharm. Corp. |
Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
|
US4647576A
(en)
*
|
1984-09-24 |
1987-03-03 |
Warner-Lambert Company |
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
|
US5001255A
(en)
*
|
1984-12-04 |
1991-03-19 |
Sandoz Pharm. Corp. |
Idene analogs of mevalonolactone and derivatives thereof
|
US4622338A
(en)
|
1985-03-11 |
1986-11-11 |
G. D. Searle & Co. |
Substituted glutaric acid lactones in the treatment of hyperlipidemia
|
US4668794A
(en)
*
|
1985-05-22 |
1987-05-26 |
Sandoz Pharm. Corp. |
Intermediate imidazole acrolein analogs
|
EP0204287A3
(fr)
*
|
1985-06-04 |
1987-07-01 |
Merck & Co. Inc. |
Procédé de préparation d'inhibiteurs de la HMG-CoA réductase ayant des sous-groupes 3,5-dihydroxy pentanoiques
|
DE3674521D1
(de)
|
1985-08-29 |
1990-10-31 |
Hoechst Ag |
6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
|
US4851427A
(en)
*
|
1985-10-25 |
1989-07-25 |
Sandoz Pharm. Corp. |
Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
|
US4654363A
(en)
*
|
1985-11-04 |
1987-03-31 |
Merck & Co., Inc. |
Synthetic analogs of mevinolin
|
DE3615620A1
(de)
*
|
1986-05-09 |
1987-11-12 |
Hoechst Ag |
4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
US4681893A
(en)
*
|
1986-05-30 |
1987-07-21 |
Warner-Lambert Company |
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
|
US4957971A
(en)
*
|
1986-07-07 |
1990-09-18 |
Warner-Lambert Company |
Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US5102893A
(en)
*
|
1986-07-07 |
1992-04-07 |
Warner-Lambert Company |
Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
NZ221717A
(en)
*
|
1986-09-10 |
1990-08-28 |
Sandoz Ltd |
Azaindole and indolizine derivatives and pharmaceutical compositions
|
US4751235A
(en)
*
|
1986-12-23 |
1988-06-14 |
Sandoz Pharm. Corp. |
Anti-atherosclerotic indolizine derivatives
|
AT388162B
(de)
*
|
1987-10-08 |
1989-05-10 |
Hoechst Ag |
4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-beta-phenylaethyl- und 6(s)-beta-styryltetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen
|
WO1989003212A1
(fr)
*
|
1987-10-13 |
1989-04-20 |
Pfizer Inc. |
Acides 3,5-dihydroxy-6,8-non adienoiques et leurs derives en tant qu'agents hypocholesterolemiques
|
US4761419A
(en)
*
|
1987-12-07 |
1988-08-02 |
Warner-Lambert Company |
6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US4863957A
(en)
*
|
1987-12-21 |
1989-09-05 |
Rorer Pharmaceutical Corporation |
Novel HMG-CoA reductase inhibitors
|
US4822799A
(en)
*
|
1988-01-27 |
1989-04-18 |
Sandoz Pharm. Corp. |
Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
|
US4906657A
(en)
*
|
1988-12-21 |
1990-03-06 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US4957940A
(en)
*
|
1988-12-21 |
1990-09-18 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US4997849A
(en)
*
|
1989-06-23 |
1991-03-05 |
Merck & Co., Inc. |
Microbial transformation of simvastatin
|
US5025017A
(en)
*
|
1989-09-28 |
1991-06-18 |
E. R. Squibb & Sons, Inc. |
Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
|
WO1992019239A1
(fr)
*
|
1991-05-01 |
1992-11-12 |
University Of New Mexico |
Traitement d'etats cellulaires aberrants a l'aide de biomodulateurs
|
WO1992019240A1
(fr)
*
|
1991-05-01 |
1992-11-12 |
University Of New Mexico |
Traitement d'aberrations cellulaires avec des biomodulateurs
|
CA2118796A1
(fr)
*
|
1991-09-20 |
1993-04-01 |
John Crosby |
Pyranones
|
CA2118795A1
(fr)
*
|
1991-09-20 |
1993-04-01 |
John Crosby |
Pyranones
|
US5296220A
(en)
*
|
1992-12-07 |
1994-03-22 |
Roelofs Wendell L |
Cockroach attractant
|
US7304091B2
(en)
*
|
2001-12-03 |
2007-12-04 |
Myco Teo A/S |
Statin-like compounds
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
US20040248972A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Ambit Biosciences Corporation |
Compounds and uses thereof
|
EP1626713A2
(fr)
*
|
2003-05-16 |
2006-02-22 |
Ambit Biosciences Corporation |
Composes heterocycliques et leurs utilisations
|
US7250444B2
(en)
*
|
2003-08-11 |
2007-07-31 |
Pfizer Inc. |
Pyrrole-based HMG-CoA reductase inhibitors
|
EP1691803A1
(fr)
*
|
2003-12-05 |
2006-08-23 |
Warner-Lambert Company LLC |
Pyrroles de n-alkyl comme inhibiteurs de l'hmg-coa-reductase
|
WO2006123355A2
(fr)
*
|
2004-11-03 |
2006-11-23 |
Sun Pharmaceutical Industries Limited |
Nouveaux derives de statine
|
US20090183503A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Alberto Verdesi |
Exhaust apparatus
|
EP3277274B1
(fr)
|
2015-04-01 |
2024-06-12 |
Cedars-Sinai Medical Center |
Analogues ou dérivés de lovastatine anti-méthanogènes et leurs utilisations
|